Boston Scientific (BSX) Tops Q4 EPS by 7c; Issues Strong Outlook; Expands Restructuring

January 29, 2013 7:05 AM

Boston Scientific Corp. (NYSE: BSX) reported Q4 EPS of $0.18, $0.07 better than the analyst estimate of $0.11. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found